It’s time to stop saying ‘long COVID’, says top doctor
The term ‘long COVID’ is causing “unnecessary fear” in the community and should no longer be used, says Queensland’s Chief Health Officer. According to Dr…
Tag: Respiratory
Infant RSV immunisation ‘highly effective’, real-world study confirms
The long-acting monoclonal antibody nirsevimab may be more effective in protecting infants against respiratory syncytial virus than clinical trial results would suggest, according to a…
Nocturnal asthma symptoms ‘should trigger treatment review’
GPs may need to step up treatment in patients with asthma-related sleep disturbances despite correct inhaler technique and adherence, according to the National Asthma Council.…
Assume all vapers, even kids, are highly nicotine dependent: smoking cessation expert
Editor’s note: The headline has been updated. It previously stated that Professor Renee Bittoun was a medical doctor, but this was incorrect. She has a…
Return to trivalent flu shots ‘likely’ as previously widespread strain disappears
Australia could switch back to trivalent influenza vaccines by next year after infectious diseases experts deemed the inclusion of one of the four strains in…
Trikafta: The life-changing wonder drug that costs $250,000 a year
There are before and after worlds in Professor Hiran Selvadurai’s respiratory ward. The ‘before’ would be a dozen or so children lying in beds with…
A GP guide to asthma in pregnancy
Asthma is a common chronic disease among women and affects more than one in 10 pregnancies, with the potential to adversely affect the health of…
Spot Dx — What’s behind this dyspnoea?
Janet is a 65-year-old recently retired caterer who presents with a week of new dyspnoea on exertion, which is affecting her golf game. Test your…
Timing of menopause and menarche influences COPD risk: study
Women who experience natural menopause before the age of 40 are nearly 70% more likely to develop COPD than those who reach menopause at 50,…
First cell-based flu vaccine listed on NIP ahead of 2024 season
A cell-based quadrivalent flu vaccine will be available on the National Immunisation Program for the first time this year for patients at higher risk of…
